Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
...ite blood cell count, an increased total number of lymphocytes and greater than 10 percent atypical lymphocytes. In keeping with the rapid proliferation of point-of-care diagnostic kits and devices, several products have now been CLIA-waived by the Centers for Disease Control and Prevention (CDC). At present, 1...Santaris Pharma Presents Positive Clinical Data on SPC2996 in Chronic Lymphocytic Leukaemia
...the drug reducingBcl-2 levels within cancerous CLL lymphocytes by bindingspecifically to and inactivating the messenger RNA for Bcl-2. Highlevels of Bcl-2 in CLL cells are associated with resistance tocancer cell death and poor disease outcome. To confirm the effectsof the novel RNA Antagonist SPC2996 on Bcl-2 l......apy, have been shownto be effective in eliminating lymphocytes in leukemia and lymphomapatients (1,2,3,4). However, a significant number of patientsrelapse after initial responses and eventually become resistant toexisting therapies. "The development of new antibody therapeutics is an importantarea of study as ...... which certain cells of the lymphsystem known as T lymphocytes become cancerous and affect the skin.CTCL can progress to the lymph nodes, spleen, liver and otherorgans. About 10% of CTCL sufferers will experience progressivedisease with lymph node and/or internal involvement with seriouscomplications. There is n......CsA, antigen-specific and non-specificresponses of lymphocytes to the protein used to induce EAU werediminished compared to those of the control group. "These positive preclinical results, combined with encouragingsafety data from human clinical trials in other indicationsconducted by our partner Isotechnika, p...Data to be presented at AAN Meeting -Study results of drug candidate for MS
...sine 1-phosphate receptor-1 (S1P-R1) oncirculating lymphocytes (white blood cells). This activityreversibly traps a proportion of lymphocytes in the lymph nodes,reducing the number of inflammatory T-cells circulating in thebloodstream and in ...